Rad Chat Live at UKIO Conference 2025 #24: Maryam Akhtarini - Hypoxia Challenge
Rad Chat · Naman Julka-Anderson and Jo McNamara
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Trigger Warning: cancer treatment, cancer and side effects.
Bonus Episode: Rad Chat Live at UKIO Conference 2025 with Maryam Akhtarini.
Stay ahead in radiotherapy and oncology by liking, following, and subscribing to Rad Chat wherever you get your podcasts.
Join our supportive community of professionals who truly get it. Follow us @Rad__Chat and visit our website at www.radchat.co.uk. Together, we’re pushing boundaries in cancer care.
Maryam’s links:
FDA Approval of Histotripsy for Liver Tumors (Oct 2023)
https://www.fda.gov/news-events/press-announcements/fda-roundup-october-13-2023
https://www.fusfoundation.org/posts/fda-approves-histotripsy-for-liver-tumors/
UK Early Market Access via IDAP (May 2025)
https://www.businesswire.com/news/home/20250529975697/en/HistoSonics-Edison-Histotripsy-System-Gains-Great-Britain-Early-Market-Access-Under-Unmet-Clinical-Needs-Authorisation
HOPE4LIVER Trial Results (April 2025)
https://www.businesswire.com/news/home/20250428931117/en/HistoSonics-Histotripsy-System-Demonstrates-90-Local-Tumor-Control-at-12-Months-in-HOPE4LIVER-Trials
https://www.fusfoundation.org/posts/histotripsy-for-liver-tumors-one-year-data-suggest-90-tumor-control/
Histotripsy Overview (Non-Thermal Ultrasound)
https://ammf.org.uk/2025/05/30/histotripsy-and-cholangiocarcinoma/
NanOx and Tumour Hypoxia – Cancer Letters (Dec 2024)
https://pubmed.ncbi.nlm.nih.gov/39716484/https://www.researchgate.net/publication/387307211_Enhancing_cancer_radiotherapy_efficacy_using_NanOx_a_novel_oxygenating_perfluorocarbon_nanoemulsion_that_reverses_tumour_hypoxia
https://www.sciencedirect.com/science/article/abs/pii/S0304383524008012
Rad Chat Links:
© Rad Chat 2025. All rights reserved.
We (or our licensors) own all intellectual property rights in this podcast and all related content, online and offline.
You may not use, copy, modify, download, archive, reproduce, distribute, display, publish, licence, create derivative works from or commercially exploit any part of our content unless we expressly agree in writing.
You must not use any images, audio, video, graphics or clips separately from their accompanying context.
Please acknowledge Rad Chat (and any identified contributors) clearly whenever referencing or sharing our content.